🇺🇸 FDA
Patent

US 10519447

Therapeutic UNA oligomers and uses thereof

granted A61KA61K31/7105A61K31/7115

Quick answer

US patent 10519447 (Therapeutic UNA oligomers and uses thereof) held by ARCTURUS THERAPEUTICS, INC. expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/7105, A61K31/7115, A61K31/7125, A61K31/713